Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Cancer Causes & Control
Erschienen in: Cancer Causes & Control 1/2006

01.02.2006 | Editorial

A Weight Loss Trial for Breast Cancer Recurrence: Pre-Menopausal, Post-Menopausal, Both, or Neither?

verfasst von: Tim Byers, Rebecca L. Sedjo

Erschienen in: Cancer Causes & Control | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Excerpt

Because the link between adiposity (overweight and obesity) and breast cancer outcomes has been apparent for many years, it seems that a randomized controlled trial to test the effects of weight loss on breast cancer recurrence is long overdue. In this commentary we will review the rationale for such a trial and comment on how emerging changes in clinical practice and surprising observations from recent research would suggest that if we had already begun such a trial we might well have designed it incorrectly. Perhaps, then, it is fortunate that such a large-scale trial has not yet been initiated. Our bottom line: whether such a trial should now be done among pre-menopausal breast cancer survivors, among post-menopausal survivors, among both, or perhaps among neither, is not clear. …
Literatur
1.
International Agency for Research on Cancer2002Weight Control and Physical ActivityInternational Agency for Research on CancerLyon
2.
Brandt, PA, Spiegelman, D, Yaun, SS,  et al. 2000Pooled analysis of prospective cohort studies on height, weight, and breast cancer riskAm J Epidemiol152514527PubMed
3.
Calle, EE, Rodriguez, C, Walker-Thurmond, K, Thun, MJ 2003Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. AdultsN Engl J Med34816251638PubMedCrossRef
4.
Lahmann, PH, Hoffmann, K, Allen, N,  et al. 2004Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)Int J Cancer111762771PubMedCrossRef
5.
Chlebowski, R, Aiello, E, McTiernan, A 2002Weight loss in breast cancer patient managementJ Clin Oncol2011281143PubMed
6.
Loi, S, Milne, RL, Friedlander, ML,  et al. 2005Obesity and outcomes in premenopausal and postmenopausal breast cancerCEBP1416861691
7.
Berclaz, C, Li, S, Price, KN,  et al. 2004Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experienceAnn Oncol15875884PubMedCrossRef
8.
Kroenke, CH, Chen, WY, Rosner, B, Holmes, MD 2005Weight, weight gain, and survival after breast cancer diagnosisJ Clin Oncol2313701378PubMed
9.
Endogenous Hormones and Breast Cancer Collaborative Group2003Body mass index, serum sex hormones, and breast cancer risk in postmenopausal womenJ Natl Cancer Inst9512181226
10.
Missmer, SA, Eliassen, H, Barbieri, RL, Hankinson, SE 2004Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal womenJ Natl Cancer Inst9618561865PubMed
11.
Sainsbury, R 2004Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy?Br J Cancer9017331739PubMed
12.
Writing Group for the Women's Health Initiative Investigators2002Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trialJAMA288321333CrossRef
13.
Fisher, B, Constantino, JP, Wickerham, DL,  et al. 1998Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJ Natl Cancer Inst9013711388PubMedCrossRef
14.
Fisher, B, Costantino, J, Redmond, C,  et al. 1989A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor positive tumorsN Engl J Med320479484PubMed
15.
Feigelson, HS, Jonas, CR, Teras, LR, Thun, MJ, Calle, EE 2004Weight gain, body mass index, hormone replacement therapy, and postmenopausal cancer in a large prospective studyCEBP13220224
16.
Dignam, JJ, Wieand, K, Johnson, KA, Fisher, B, Xu, L, Mamounas, EP 2003Obesity, Tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancerJ Natl Cancer Inst9514671476PubMed
17.
Holmes, MD, Chen, WY, Feskanich, D, Kroenke, CH, Colditz, GA 2005Physical activity and survival after breast cancer diagnosisJAMA29324792486PubMedCrossRef
18.
McTiernan, A, Tworoger, SS, Ulrich, CM,  et al. 2004Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trialCancer Res6429232928PubMedCrossRef
19.
Williamson, DF, Pamuk, E, Thun, M, Flanders, D, Byers, T, Heath, C 1995Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40–64 yearsAm J Epidemiol14111281141PubMed
20.
Harvie, M, Howell, A, Vierkant, RA,  et al. 2005Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa Women's Health StudyCEBP14656661
21.
Demark-Wahnefried, W, Rimer, BK, Winer, EP 1997Weight gain in women diagnosed with breast cancerJ Am Diet Assoc97519526PubMed
22.
Winer, EP, Hudis, C, Burstein, HJ,  et al. 2005American Society of Clinical Oncology Technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004J Clin Oncol23111
23.
Daling, J, Malone, K, Doody, D, Johnson, LG, Gralow, JR, Porter, PL 2001Relation of body mass index to tumor markers and survival among young women with invasive ductal breast cancerCancer92720729PubMedCrossRef
24.
Whiteman, M, Hillis, S, Curtis, K, McDonald, J, Wingo, P, Marchbanks, P 2005Body mass and mortality after breast cancer diagnosisCancer Epidemiol Biomarkers Prev1420092014PubMed
25.
Rose, D, Komninou, D, Stephenson, G 2004Obesity, adipocytokines, and insulin resistance in breast cancerObes Rev5153165PubMedCrossRef
26.
Wing, RR, Hamman, RF, Bray, GA,  et al. 2004Achieving weight and activity goals among diabetes prevention program lifestyle participantsObes Res1214261434PubMed
27.
Tuomilehto, J, Lindstrom, J, Eriksson, JG,  et al. 2001Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose toleranceN Engl J Med34413431350PubMedCrossRef
28.
Brown, J, Byers, T, Thompson, K,  et al. 2001Nutrition during and after cancer treatment: a guide for informed choices by cancer survivorsCA Cancer J Clin51153187PubMedCrossRef
29.
Prentice, RL, Willett, WC, Greenwald, P,  et al. 2004Nutrition and physical activity and chronic disease prevention. Research strategies and recommendationsJ Natl Cancer Inst9612761287PubMed
Metadaten
Titel
A Weight Loss Trial for Breast Cancer Recurrence: Pre-Menopausal, Post-Menopausal, Both, or Neither?
verfasst von
Tim Byers
Rebecca L. Sedjo
Publikationsdatum
01.02.2006
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 1/2006
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-0547-4

Weitere Artikel der Ausgabe 1/2006

Cancer Causes & Control 1/2006 Zur Ausgabe

Original Paper

Results of a Union-based Smoking Cessation Intervention for Apprentice Iron Workers (United States)

Original Paper

Breast Cancer and Night Work among Norwegian Nurses

Original Paper

Reliability and Validity of an Assessment of Usual Phytoestrogen Consumption (United States)

Original Paper

Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States)

Original Paper

Pregnancy History and Incidence of Melanoma in Women: A Pooled Analysis

Original Paper

Physical Activity and Risk of Ovarian Cancer: Results from the Netherlands Cohort Study (The Netherlands)

Neu im Fachgebiet Onkologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise